Summit Therapeutics Inc
SMMT
Market Cap$2.85B
Close$
$-0.07
101.3% downside
Current Fair Value
101.3% downsideOvervalued by 101.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.85 Billion |
|---|---|
| Enterprise Value | $2.74 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.45 |
| Beta | 2.07 |
| Outstanding Shares | 701,979,596 |
| Avg 30 Day Volume | 1,875,038 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.77 |
|---|---|
| PEG | 38.93 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 12464.92 |
| Enterprise Value to EBIT | -4.71 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.9 |
Revenue Sources
No data
ESG Score
No data